Hide

FocusBar

Subscribe to Premium Member
Switch to:

GuruFocus Financial Strength Rank measures how strong a companyย’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.965
CHDX's Cash to Debt is ranked higher than
58% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.95 vs. CHDX: 0.965 )
CHDX' s 10-Year Cash to Debt Range
Min: 0.77   Max: No Debt
Current: 0.97

Equity to Asset 0.675
CHDX's Equity to Asset is ranked higher than
83% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.40 vs. CHDX: 0.675 )
CHDX' s 10-Year Equity to Asset Range
Min: 0.32   Max: 0.72
Current: 0.68

0.32
0.72
Interest Coverage No Debt
CHDX's Interest Coverage is ranked higher than
90% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 18.90 vs. CHDX: No Debt )
CHDX' s 10-Year Interest Coverage Range
Min: 1   Max: No Debt
Current: No Debt

F-Score: 6
Z-Score: 3.42
M-Score: -3.51
GuruFocus Profitability Rank ranks how profitable a company is and how likely the companyย’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
ย•ย•3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rankย•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating margin (%) 6.20
CHDX's Operating margin (%) is ranked higher than
71% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.60 vs. CHDX: 6.20 )
CHDX' s 10-Year Operating margin (%) Range
Min: -714.6   Max: 8.4
Current: 6.2

-714.6
8.4
Net-margin (%) 2.7
CHDX's Net-margin (%) is ranked higher than
62% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.30 vs. CHDX: 2.7 )
CHDX' s 10-Year Net-margin (%) Range
Min: -9.3   Max: 4.8
Current: 2.7

-9.3
4.8
ROE (%) 2.7
CHDX's ROE (%) is ranked lower than
67% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.20 vs. CHDX: 2.7 )
CHDX' s 10-Year ROE (%) Range
Min: -22.7   Max: 9.8
Current: 2.7

-22.7
9.8
ROA (%) 1.8
CHDX's ROA (%) is ranked lower than
60% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.90 vs. CHDX: 1.8 )
CHDX' s 10-Year ROA (%) Range
Min: -9.9   Max: 4.8
Current: 1.8

-9.9
4.8
ROC (Joel Greenblatt) (%) 10.30
CHDX's ROC (Joel Greenblatt) (%) is ranked lower than
58% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 26.40 vs. CHDX: 10.30 )
CHDX' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -5307.7   Max: 35.2
Current: 10.3

-5307.7
35.2
Revenue Growth (%) -5.3
CHDX's Revenue Growth (%) is ranked lower than
77% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.90 vs. CHDX: -5.3 )
CHDX' s 10-Year Revenue Growth (%) Range
Min: -12.4   Max: 25.1
Current: -5.3

-12.4
25.1
EBITDA Growth (%) 7.1
CHDX's EBITDA Growth (%) is ranked higher than
73% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.70 vs. CHDX: 7.1 )
CHDX' s 10-Year EBITDA Growth (%) Range
Min: -71.4   Max: 235.4
Current: 7.1

-71.4
235.4
EPS Growth (%) -6.2
CHDX's EPS Growth (%) is ranked lower than
79% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.00 vs. CHDX: -6.2 )
CHDX' s 10-Year EPS Growth (%) Range
Min: -8   Max: 21.3
Current: -6.2

-8
21.3
ยป CHDX's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q4 2011

CHDX Guru Trades in Q4 2011

Jim Simons 37,300 sh (-53.55%)
» More
Q1 2012

CHDX Guru Trades in Q1 2012

Jim Simons 18,400 sh (-50.67%)
» More
Q2 2012

CHDX Guru Trades in Q2 2012

Jim Simons Sold Out
» More
Q1 2013

CHDX Guru Trades in Q1 2013

Jim Simons 14,311 sh (New)
» More
» Details

Insider Trades

Latest Guru Trades with CHDX



No Insider Trades Found!
ยป Financial Charts

Peter Lynch Chart

Ratios

vs
industry
vs
history
P/E(ttm) 59.90
CHDX's P/E(ttm) is ranked lower than
76% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 19.90 vs. CHDX: 59.90 )
CHDX' s 10-Year P/E(ttm) Range
Min: 5.92   Max: 383.18
Current: 59.9

5.92
383.18
P/B 1.80
CHDX's P/B is ranked higher than
59% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.25 vs. CHDX: 1.80 )
CHDX' s 10-Year P/B Range
Min: 0.49   Max: 8.57
Current: 1.8

0.49
8.57
P/S 1.70
CHDX's P/S is ranked lower than
71% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.48 vs. CHDX: 1.70 )
CHDX' s 10-Year P/S Range
Min: 0.09   Max: 2.85
Current: 1.7

0.09
2.85
EV-to-EBIT 23.8
CHDX's EV-to-EBIT is ranked lower than
68% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.30 vs. CHDX: 23.8 )
CHDX' s 10-Year EV-to-EBIT Range
Min: 1.4   Max: 224.6
Current: 23.8

1.4
224.6
Shiller P/E 48.6
CHDX's Shiller P/E is ranked lower than
100% of the Companies
in the Global Medical Distribution industry.

( Industry Median: vs. CHDX: 48.6 )
CHDX' s 10-Year Shiller P/E Range
Min: 26.93   Max: 1515
Current: 48.6

26.93
1515

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 18
CHDX's Price/Net Current Asset Value is ranked lower than
72% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.50 vs. CHDX: 18 )
CHDX' s 10-Year Price/Net Current Asset Value Range
Min: 0.4   Max: 14.6
Current: 18

0.4
14.6
Price/Tangible Book 1.8
CHDX's Price/Tangible Book is ranked higher than
61% of the 33 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.50 vs. CHDX: 1.8 )
CHDX' s 10-Year Price/Tangible Book Range
Min: 0.4   Max: 5
Current: 1.8

0.4
5
Price/DCF (Projected) 2.8
CHDX's Price/DCF (Projected) is ranked lower than
63% of the 24 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.00 vs. CHDX: 2.8 )
CHDX' s 10-Year Price/DCF (Projected) Range
Min: 1.3   Max: 9.3
Current: 2.8

1.3
9.3
Price/Median PS Value 2.3
CHDX's Price/Median PS Value is ranked lower than
79% of the 42 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.10 vs. CHDX: 2.3 )
CHDX' s 10-Year Price/Median PS Value Range
Min: 0.1   Max: 3.4
Current: 2.3

0.1
3.4
Price/Graham Number 2.4
CHDX's Price/Graham Number is ranked lower than
66% of the 35 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.70 vs. CHDX: 2.4 )
CHDX' s 10-Year Price/Graham Number Range
Min: 0.4   Max: 6.7
Current: 2.4

0.4
6.7
Earnings Yield (Greenblatt) 4.20
CHDX's Earnings Yield (Greenblatt) is ranked lower than
56% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 8.20 vs. CHDX: 4.20 )
CHDX' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.4   Max: 73.2
Current: 4.2

0.4
73.2
Forward Rate of Return (Yacktman) -8.88
CHDX's Forward Rate of Return (Yacktman) is ranked lower than
77% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.00 vs. CHDX: -8.88 )
CHDX' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -21.4   Max: 11.4
Current: -8.88

-21.4
11.4

Business Description

Chindex International, Inc. was founded in 1981. The Company operates in several healthcare markets in China, including Hong Kong. The company is generat its revenue from the provision of healthcare services and the sale of medical equipment, instrumentation and products. The Company operates in two business segments: Healthcare Services division and Medical Products division. Healthcare Services division - this division operates the Company's United Family Healthcare network of private hospitals and clinics. United Family Healthcare currently owns and operates hospitals and affiliated clinic facilities in the Beijing, Shanghai and Guangzhou markets. The division also operates a managed clinic in the city of Wuxi, south of Shanghai. It has undertaken a number of market expansion projects in its current markets. In Beijing, it expects to significantly increase service offerings and more than double its available beds through expansion currently underway at its existing hospital campus as well as from the opening of two additional affiliated clinics. Medical Products division - this division markets, distributes and sells select medical capital equipment, instrumentation and other medical products for use in hospitals in China and Hong Kong on the basis of both exclusive and non-exclusive agreements with the manufacturers of these products. The division revenues are generated through a nation-wide direct sales force that also manages local sub-dealers regionally throughout the country. The division's distribution business provides supply chain management and logistics services to both divisions of the Company.
Company Website
SEC Reports
Industry: Medical Distribution
Compare:ABC, MCK, CAH, SHTDF, HSIC

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK